Technology 95 of 293
Genomic analysis
7 EIC Accelerator winners build on Genomic analysis, 1% of the classified companies, in 2 sectors and 5 industries.
7
Companies
2
Sectors
5
Industries
7
Countries
0%
Exits
71%
Show signs of scaling
Sectors
- Health6 (86%)
- Agrifood1 (14%)
Industries
Used together with
Other technologies of the same companies
Companies per year of first award
2019
2020
2021
2022
2023
2024
2025
2026
- Genomic analysis
Show the numbers
| Companies | Genomic analysis | |
|---|---|---|
| 2019 | 4 | 4 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 2 | 2 |
| 2026 | 0 | 0 |
What happened to them (7 of 7 checked)
- Active5 (71%)
- Exit0 (0%)
- Failed1 (14%)
- Other1 (14%)
Signs of scaling
- Scaling5 (71%)
- Not scaling1 (14%)
- Scaling unclear1 (14%)
Keywords
- Antidepressant selection
- Antivirals
- Biopsy reduction
- Breast cancer
- Cosmetics
- COVID-19
- Crop disease risk
- Depression
- DNA sequencing
- Drug repurposing
- Fluorescence in situ hybridisation
- Gene expression profiling
- Genetic testing
- Hepatocellular carcinoma
- Influenza
- Laser microdissection
- Liver transplantation
- Melanoma
- Metagenomics
- Next-generation sequencing
- Oncology
- Patient selection
- Pharmacogenomics
- Psychiatry
- Regenerative agriculture
- RNA sequencing
- Single-cell analysis
- Skin cancer screening
- Skin health
- Soil health
- Soil microbiome
- Spatial biology
- Transcriptomics
- Tumour profiling
All 7 companies using Genomic analysis
| Company | Project | Industry | Country | Cut-off | Funding | Status | Report |
|---|---|---|---|---|---|---|---|
| Mitra Bio Limited | MitraTestA NOVEL NON-INVASIVE DNA METHYLATION TEST FOR MELANOMA | In vitro diagnostics | United Kingdom | March 2025 | Grant only | Active | Deep dive |
| Single Technologies AB | Theta128Breaking the 2-dimensional sequencing barrier with ultra low-cost (<$10), fast 3D image-based sequencing | Life science tools | Sweden | March 2025 | Blended finance | Active | Deep dive |
| SIGNIA THERAPEUTICS SAS | SigniaAn innovative drug development and repurposing platform for rapid identification and validation of antimicrobial therapeutics | Biopharmaceuticals | France | January 2020 | Grant only | Closed | Deep dive |
| Biome Makers Spain SL | BeCropSMART MICROBIOME-BASED PLATFORM FOR THE EARLY DETECTION OF BIOLOGICAL THREATS IN AGRICULTURE | Digital agriculture | Spain | October 2019 | Grant only | Active | Deep dive |
| MultiplexDX, s.r.o. | Multiplex8+A highly accurate breast cancer diagnostic test for effective personalized treatment and assessment of therapy response. | In vitro diagnostics | Slovakia | October 2019 | Grant only | Active | Deep dive |
| OPHIOMICS - INVESTIGAÇÃO E DESENVOLVIMENTO EM BIOTECNOLOGIA, S.A. | HepatoPredictHepatoPredict, A decision tool for Liver Transplantation based on molecular signature | In vitro diagnostics | Portugal | October 2019 | Blended finance | Active | Deep dive |
| TALIAZ LTD | PredictixPredictix ™ - a user-friendly procedure that analyses genomic, clinical and demographic data to generate a personalized report on the efficacy of antidepressants and their side effects | Digital health | Israel | April 2019 | Grant only | Pivoted | Deep dive |